Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
FGEN Fibrogen Inc
- Stocks
- Healthcare
- NASDAQ: FGEN
Price (delayed)
$5.61
Market cap
$22.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.5
Enterprise value
$121.65M
FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue
Highlights
The net income has surged by 96% year-on-year and by 79% since the previous quarter
The company's EPS has surged by 96% YoY and by 79% QoQ
The quick ratio has plunged by 58% YoY but it has grown by 21% from the previous quarter
FGEN's gross profit has dropped by 197% since the previous quarter and by 196% year-on-year
The company's revenue has shrunk by 179% QoQ and by 165% YoY
Key stats
What are the main financial stats of FGEN
Market
Valuations
Earnings
Shares outstanding
4.04M
Market cap
$22.67M
Enterprise value
$121.65M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
-$23.54M
Gross profit
-$13.6M
Operating income
-$134.27M
Net income
-$10.01M
EBIT
-$4.8M
EBITDA
-$2.6M
Free cash flow
-$75.2M
Per share
Balance sheet
Liquidity
EPS
-$2.5
EPS diluted
-$2.5
Free cash flow per share
-$18.62
Book value per share
-$53.73
Revenue per share
-$5.83
TBVPS
$40.91
Total assets
$165.21M
Total liabilities
$340.14M
Debt
$132.59M
Equity
-$216.9M
Working capital
$75.14M
Debt to equity
-0.61
Current ratio
2.02
Quick ratio
0.46
Net debt/EBITDA
-38.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-4.3%
Return on equity
N/A
Return on invested capital
-3%
Return on capital employed
-5.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FGEN stock price
How has the Fibrogen stock price performed over time
Intraday
6.86%
1 week
5.85%
1 month
-25.5%
1 year
-67.53%
YTD
-57.63%
QTD
5.85%
Financial performance
How have Fibrogen's revenue and profit performed over time
Revenue
-$23.54M
Gross profit
-$13.6M
Operating income
-$134.27M
Net income
-$10.01M
Gross margin
N/A
Net margin
N/A
FGEN's gross profit has dropped by 197% since the previous quarter and by 196% year-on-year
The company's revenue has shrunk by 179% QoQ and by 165% YoY
The net income has surged by 96% year-on-year and by 79% since the previous quarter
FGEN's operating income has surged by 55% year-on-year and by 11% since the previous quarter
Price vs fundamentals
How does FGEN's price correlate with its fundamentals
Growth
What is Fibrogen's growth rate over time
Valuation
What is Fibrogen stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 96% YoY and by 79% QoQ
FGEN's equity is up by 4.9% year-on-year and by 3.9% since the previous quarter
The company's revenue has shrunk by 179% QoQ and by 165% YoY
Efficiency
How efficient is Fibrogen business performance
FGEN's return on invested capital has surged by 96% year-on-year and by 87% since the previous quarter
FGEN's return on assets has surged by 92% year-on-year and by 74% since the previous quarter
Dividends
What is FGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FGEN.
Financial health
How did Fibrogen financials performed over time
FGEN's total assets is 51% smaller than its total liabilities
The quick ratio has plunged by 58% YoY but it has grown by 21% from the previous quarter
FGEN's total assets has dropped by 55% year-on-year and by 23% since the previous quarter
The company's debt is 161% higher than its equity
The company's debt fell by 34% YoY
FGEN's debt to equity is up by 31% YoY but it is down by 5% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.